Changes in Left Ventricular Diastolic Function 6 Months After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
Key result
Nonsurgical septal reduction therapy significantly reduced LVOT gradient (53.6 to 6 mm Hg, P<0.001) and improved LV relaxation and compliance at 6 months.
Why the study?
Does nonsurgical septal reduction therapy improve left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy?
Population
29 patients with hypertrophic obstructive cardiomyopathy (HOCM) and baseline NYHA class III.
Design
Cohort
Follow-up
6 months
Authors
Discussion
Loading...
Member takes
Implication
NSRT may improve LV relaxation and compliance in HOCM; supports mechanistic link to symptom relief but leaves open confirmation in randomized trials.
Key Points
- The research aims to evaluate the impact of nonsurgical septal reduction therapy on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy patients.
- 29 hypertrophic obstructive cardiomyopathy patients underwent Doppler echocardiography at baseline and 6 months post-therapy.
- Measurements included LV volume, pre-A-wave pressure, early diastolic mitral annulus velocity, and tau.
- Statistical analysis was conducted to assess changes pre- and post-treatment.
- LVOT gradient significantly reduced from 53.6±15 to 6±5 mm Hg (P<0.001).
- Pre-A pressure decreased from 18±6 to 14±5 mm Hg (P<0.01), and tau decreased from 62±8 to 51±8 ms (P<0.01).
- Early diastolic mitral annulus velocity (Ea) increased from 5.8±1.8 to 8±1.8 cml/s (P<0.01).
Study Design
Type
Observational (n=29)
Structured PICO
Does nonsurgical septal reduction therapy improve left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy?
P
Population
29 patients with hypertrophic obstructive cardiomyopathy evaluated at baseline and 6 months after nonsurgical septal reduction therapy.
E
Exposure
Nonsurgical septal reduction therapy (NSRT)
O
Outcome
Changes in left ventricular diastolic function (LV volume, pre-A-wave pressure, early diastolic mitral annulus velocity [Ea], and tau) at 6 monthssurrogate
Main Result
p-value: p=<0.01
Nonsurgical septal reduction therapy significantly improves left ventricular relaxation and compliance at 6 months, which correlates with symptomatic and exercise capacity improvements in HOCM patients.
Cite This Study
Nagueh et al. (1999) conducted an observational in Hypertrophic obstructive cardiomyopathy (n=29). Nonsurgical septal reduction therapy (NSRT) vs. Baseline was evaluated on Changes in left ventricular diastolic function (pre-A pressure, tau, Ea, and LV end-diastolic volume) (p=<0.01). Nonsurgical septal reduction therapy significantly reduced LVOT gradient (53.6 to 6 mm Hg, P<0.001) and improved LV relaxation and compliance at 6 months.